Ciprodex · DIN 02252716 · 0.3% w/v & 0.1% w/v · Otic suspension-7.5mL Pk (With Preservative)
Limited Use — Reason for Use code 509 requiredMarketed · checked 2026-09-19
StatusLimited Use — Reason for Use code 509 required
Write on scriptLU code 509 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 509
Reason for Use code 509
The treatment of otitis externa in patients:
- With known perforated tympanic membrane or ventilation tubes;
OR
- Requiring chronic therapy (i.e., more than 14 days);
OR
- Who have been receiving more than 7 days of topical aminoglycoside therapy without improvement, where there is concern of a resistant pathogen;
OR
- With documented pre-existing hearing impairment.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Ciprodex · DIN 02252716
Manufacturer: Novartis Pharma Canada Inc.; listing date 2018-06-29
Health Canada: Marketed since 2018-06-11 · brand CIPRODEX · ATC S02CA06 DEXAMETHASONE AND ANTIINFECTIVES · form Suspension · route Otic · ingredients CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 %/W/V, DEXAMETHASONE 0.1 %/W/V · company Novartis pharmaceuticals canada inc · schedule Prescription
Ministry pays: $14.4203 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73758 · Verify on the e-Formulary ↗ (DIN 02252716)
Source record
DIN 02252716: Ciprodex
Raw flags: sec12=Y, sec3=Y
Item: 520404046; group id 575; item number 1529; lccId 00306; manufacturer id NOV
Source form: Otic Susp-7.5mL Pk (With Preservative); strength: 0.3% w/v & 0.1% w/v
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $32.6094; ministry $14.4203
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02252716
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73758
Interchangeable products
Sandoz Ciprofloxacin/Dexamethasone · DIN 02506882 · $14.4203
Taro-Ciprofloxacin/Dexamethasone · DIN 02481901 · $14.4203
Shortage status: not checked (no credentials)